Page last updated: 2024-08-16

procyclidine and isocarboxazid

procyclidine has been researched along with isocarboxazid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bucci, L1
Bergman, H; Soares-Weiser, K1

Reviews

2 review(s) available for procyclidine and isocarboxazid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
    The Cochrane database of systematic reviews, 2018, 01-17, Volume: 1

    Topics: Antipsychotic Agents; Biperiden; Cholinergic Antagonists; Dyskinesia, Drug-Induced; Humans; Isocarboxazid; Procyclidine; Randomized Controlled Trials as Topic; Schizophrenia; Withholding Treatment

2018

Trials

1 trial(s) available for procyclidine and isocarboxazid

ArticleYear
The dyskenesias: a new therapeutic approach.
    Diseases of the nervous system, 1971, Volume: 32, Issue:5

    Topics: Chlorpromazine; Clinical Trials as Topic; Female; Humans; Isocarboxazid; Male; Middle Aged; Monoamine Oxidase Inhibitors; Movement Disorders; Phenothiazines; Procyclidine; Schizophrenia

1971

Other Studies

1 other study(ies) available for procyclidine and isocarboxazid

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011